Skip to main content

LUP Student Papers

LUND UNIVERSITY LIBRARIES

Webbaserat beslutsstöd och kvalitetsvärdering vid kronisk myeloisk leukemi

Dahlqvist, Viveca LU (2013) LÄKM01 20122
MD Programme
Abstract
INTRODUCTION
RealQ-KML is a clinical decision support system combined with tools for quality assessment for chronic myeloid leukemia (CML). Thanks to the introduction of modern treatment CML is a chronic disease, which during its follow-up generates large quantities of data. The aim of this study was to evaluate how this program could be used at the Department of Hematology, at Skåne University Hospital, to identify benefits and limitations, as well as to obtain qualitative data about the patients of the department.

RealQ-KML
The decision support in the program visualizes the patients course of disease and automatically calculates treatment response according to guidelines. Registered data will also be able to be used for reporting to... (More)
INTRODUCTION
RealQ-KML is a clinical decision support system combined with tools for quality assessment for chronic myeloid leukemia (CML). Thanks to the introduction of modern treatment CML is a chronic disease, which during its follow-up generates large quantities of data. The aim of this study was to evaluate how this program could be used at the Department of Hematology, at Skåne University Hospital, to identify benefits and limitations, as well as to obtain qualitative data about the patients of the department.

RealQ-KML
The decision support in the program visualizes the patients course of disease and automatically calculates treatment response according to guidelines. Registered data will also be able to be used for reporting to the national quality register. The program further allows to make a quality assessment over all patients at the clinic by calculating quality factors and allowing data to be extracted for research.

RESULTS AND DISCUSSION
95 patients at the department have been registered and statistical data extracted. During the study both benefits and limitations were found. As RealQ-KML is still under development, some problems may be addressed, while others are inherent to the RealQ-platform or general limitations of computer programs. There are high expectations that clinical decision support programs will increase efficiency, and while studies do confirm some effects, there is still not enough evidence to support widespread use. RealQ-KML offers a range of interesting tools to the clinic, but needs further development to reach its full potential. (Less)
Please use this url to cite or link to this publication:
author
Dahlqvist, Viveca LU
supervisor
organization
alternative title
Web-based clinical decision support system and quality assessment in chronic myeloid leukemia
course
LÄKM01 20122
year
type
H2 - Master's Degree (Two Years)
subject
keywords
kronisk myeloisk leukemi, beslutsstöd, it-stöd, RealQ-KML
language
Swedish
id
3365054
date added to LUP
2014-04-09 10:38:38
date last changed
2014-04-09 10:38:38
@misc{3365054,
  abstract     = {INTRODUCTION
RealQ-KML is a clinical decision support system combined with tools for quality assessment for chronic myeloid leukemia (CML). Thanks to the introduction of modern treatment CML is a chronic disease, which during its follow-up generates large quantities of data. The aim of this study was to evaluate how this program could be used at the Department of Hematology, at Skåne University Hospital, to identify benefits and limitations, as well as to obtain qualitative data about the patients of the department.

RealQ-KML
The decision support in the program visualizes the patients course of disease and automatically calculates treatment response according to guidelines. Registered data will also be able to be used for reporting to the national quality register. The program further allows to make a quality assessment over all patients at the clinic by calculating quality factors and allowing data to be extracted for research.

RESULTS AND DISCUSSION 
95 patients at the department have been registered and statistical data extracted. During the study both benefits and limitations were found. As RealQ-KML is still under development, some problems may be addressed, while others are inherent to the RealQ-platform or general limitations of computer programs. There are high expectations that clinical decision support programs will increase efficiency, and while studies do confirm some effects, there is still not enough evidence to support widespread use. RealQ-KML offers a range of interesting tools to the clinic, but needs further development to reach its full potential.},
  author       = {Dahlqvist, Viveca},
  keyword      = {kronisk myeloisk leukemi,beslutsstöd,it-stöd,RealQ-KML},
  language     = {swe},
  note         = {Student Paper},
  title        = {Webbaserat beslutsstöd och kvalitetsvärdering vid kronisk myeloisk leukemi},
  year         = {2013},
}